Comparison of rapidity of coronary recanalization in men with tenecteplase versus alteplase in acute myocardial infarction.

Azan S Binbrek, Nayan S Rao, Dagnija Neimane, Eman Hatou, Sultan Abdulali, Burton E Sobel

Journal: The American journal of cardiology 2004;93(12):1465-8

PMID: 15194014

Full Text on Elsevier Science View on PubMed

Abstract

To determine whether tenecteplase (TNK-t-PA), a bioengineered variant of tissue-type plasminogen activator (t-PA) designed to accelerate thrombolysis, exhibits favorable properties compared with those of alteplase, 266 men were studied

Address: Rashid Hospital, Dubai, United Arab Emirates.

DOI: 10.1016/j.amjcard.2004.03.004

Link outs

Free resources

Medical:

https://medlineplus.gov/heartattack.html

Subscription / membership required

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S0002...

MeSH Terms: Adult, Aged, Aspirin, Creatine Kinase, Creatine Kinase, MM Form, Dose-Response Relationship, Drug, Fibrinolytic Agents, Heparin, Humans, Isoenzymes, Male, Middle Aged, Myocardial Infarction, Tenecteplase, Thrombolytic Therapy, Time Factors, Tissue Plasminogen Activator, Treatment Outcome